MUMSS
JAZZ icon

Mitsubishi UFJ Morgan Stanley Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$5K Buy
+30
New +$4.98K 0.01% 252

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Morgan Stanley Securities's JAZZ Position: Q4 2014 in Review

Mitsubishi UFJ Morgan Stanley Securities opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2014: 30 shares worth $5K. The stake represents 0.01% of the portfolio and ranks #252 among its holdings.

357 funds tracked by Wall St. Rank hold JAZZ as of Q4 2014.

  • Mitsubishi UFJ Morgan Stanley Securities held 30 shares of Jazz Pharmaceuticals worth $5K as of Q4 2014.
  • Jazz Pharmaceuticals was a new Mitsubishi UFJ Morgan Stanley Securities position in Q4 2014.
  • Jazz Pharmaceuticals made up 0.01% of Mitsubishi UFJ Morgan Stanley Securities's portfolio in Q4 2014, its #252 holding.
  • 357 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2014.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q4 2014, filed 17 Feb 2015.